9 August 2022
ECO Animal Health Group plc
(''ECO", the "Company" or the "ECO Group") (AIM: EAH)
Directorate Change
ECO Animal Health plc announces today that Tony Rawlinson, Non-Executive Director, has resigned from the Board to pursue other business opportunities, with immediate effect.
Andrew Jones the Chairman of ECO Animal Health commented:
"Tony has been a Non-Executive Director at ECO Animal Health plc for nearly eight years and has been involved in the development and implementation of important changes in corporate governance and remuneration policy. The Board sincerely thanks him for his much-valued contribution and wish him well for the future."
For further information please contact:
| ECO Animal Health Group plc David Hallas (CEO) Christopher Wilks (CFO)
| 020 8447 8899
|
|
IFC Advisory Graham Herring Zach Cohen
|
020 3934 6630
|
|
Singer Capital Markets (Nominated Adviser & Joint Broker) Mark Taylor George Tzimas |
020 7496 3000 |
|
Investec (Joint Broker) Gary Clarence Brough Ransom Carlo Spingardi
Peel Hunt LLP (Joint Broker) Dr Christopher Golden James Steel |
020 7597 5970
020 7418 8900 |
| Equity Development Hannah Crowe Matt Evans | 020 7065 2692 |
About ECO Animal Health
ECO Animal Health Group plc researches, develops and commercialises products for livestock. Our business strategy is to generate shareholder value by achieving the maximum sales potential from the existing product portfolio whilst investing in Research and Development ("R&D") for new products, particularly vaccines, and seeking to in-license new products.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
